← Open Payments lookup

TRACY ESTES: Open Payments

NPI 1194919506 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$13,846 in 147 payments from 20 companies in 2025. Trend: 2023 $19,296 · 2024 $15,051 · 2025 $13,846

Consulting: $7,152Food & beverage: $3,320Travel & lodging: $3,273Education: $100
CompanyPaymentsAmount
Pharming Healthcare, Inc.50$11,408
GENZYME CORPORATION9$387
AstraZeneca Pharmaceuticals LP17$363
GlaxoSmithKline, LLC.11$290
CSL Behring9$231
Takeda Pharmaceuticals U.S.A., Inc.10$223
Novartis Pharmaceuticals Corporation11$196
Ionis Pharmaceuticals, Inc.7$163
LEO Pharma Inc.3$155
ARS Pharmaceuticals Operations, Inc.6$107

Products named: RUCONEST, DUPIXENT, NUCALA, TEZSPIRE, ANZUPGO, TAKHZYRO, Hizentra, NEFFY.

Industry payments across DE — which companies pay providers there.